BioDrugs

Aims & Scope

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

The Journal includes: - Definitive reviews on topics relating to the development and use of biotechnology in healthcare and the management of disease. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Original research articles on the clinical development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products. - Leading/Current Opinion articles providing an overview of contentious or emerging issues and key regulatory and ethical issues. - Adis Drug Evaluations reviewing the properties and place in therapy of biotechnology-based drugs. - Adis Biosimilar Briefs summarizing key characteristics and clinical use of biosimilar drugs.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	6.9
2024	5.40

SJR (SCImago Journal Rank)

Year	Value
2024	2.290

Quartile

Year	Value
2024	Q1

Journal Rank

Year	Value
2024	1117

Journal Citation Indicator

Year	Value
2024	1115

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Adeno-Associated Virus (AAV) as a Vector for Gene Therapy

  Citation: 1048

  Authors: Michael F., Brian, William L., William R.

• The Impact of PEGylation on Biological Therapies

  Citation: 834

  Authors: Francesco M, Anna

• The Therapeutic Potential of Nanobodies

  Citation: 598

  Authors: Ivana, Serge

• Oral Delivery of Peptide Drugs

  Citation: 383

  Authors: Josias H, Gill M, Awie F

• Glycosylation of Therapeutic Proteins

  Citation: 381

  Authors: Ricardo J., Kai

• Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters

  Citation: 375

  Authors: William R.

• Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities

  Citation: 341

  Authors: Beate, Wolfgang, Johannes

• Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders

  Citation: 337

  Authors: Keri, Blair

• The Application of Recombinant Human Collagen in Tissue Engineering

  Citation: 311

  Authors: Chunlin, Patrick J, Julio A, Minna, Juliana, James, Robert, James W

• Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review

  Citation: 284

  Authors: Vibeke, Alejandro, Jamal, Leonor, Takahiko, Tsutomu, Sadiq, Charles, Blerina, Lisa

---